| HOME >> MEDICINE >> TECHNOLOGY |
$
246,746
$
256,290(3.7) Diabetes Care104,81998,6336.3 Pharmaceutical Systems52,73645,30816.4TOTAL
$
404,301
$
400,2311.0BD DIAGNOSTICS Preanalytical Systems
$
161,556
$
162,024(0.3) Diagnostic Systems152,047145,6974.4TOTAL
$
313,603
$
307,7211.9BD BIOSCIENCES Cell Analysis
$
89,899
$
86,7653.6 Discovery Labware34,72037,244(6.8)TOTAL
$
124,619
$
124,0090.5TOTAL UNITED STATES
$
842,523
$
831,9611.3Page 5 BECTON DICKINSON AND COMPANYSUPPLEMENTAL REVENUE INFORMATIONREVENUES BY BUSINESS SEGMENTS AND UNITSThree Months Ended September 30, (continued)(Unaudited; Amounts in thousands)International % Change 20112010 Reported FXNFX ImpactBD MEDICAL Medical Surgical Systems
$
288,653
$
245,72417.57.89.7 Diabetes Care119,832100,46819.37.611.7 Pharmaceutical Systems241,805212,18214.02.511.5TOTAL
$
650,290
$
558,37416.55.810.7BD DIAGNOSTICS Preanalytical Systems
$
167,044
$
144,42115.75.710.0 Diagnostic Systems161,401139,32215.86.29.6TOTAL
$
328,445
$
283,74315.85.99.9BD BIOSCIENCES Cell Analysis
$
183,259
$
160,23014.46.87.6 Discovery Labware46,27838,88719.09.59.5TOTAL
$
229,537
$
199,11715.37.38.0TOTAL INTERNATIONAL
$
1,208,272
$
1,041,23416.06.19.9Page 6BECTON DICKINSON AND COMPANYSUPPLEMENTAL REVENUE INFORMATIONREVENUES BY BUSINESS SEGMENTS AND UNITSThree Months Ended September 30,
'/>"/>
| SOURCE BD (Becton, Dickinson and Company) Copyright©2010 PR Newswire. All rights reserved |